Florida has reduced funding and tightened eligibility for its AIDS Drug Assistance Program, limiting access to the widely used HIV medication Biktarvy for thousands of patients, while more than 20 ...

By HealthDay Staff HealthDay ReporterTUESDAY, March, 3, 2026 (HealthDay News) — A growing number of states are rolling back ...

Florida Governor Ron DeSantis is using his emergency powers to end coverage for an estimated 10,000 to 16,000 HIV/AIDS patients from the state's AIDS Drug Assistance Program, which advocates say could ...

After he was prescribed Otezla, a brand-name drug commonly used to control inflammation linked to the condition, Mishra says ...

Florida has one of the highest rates of new HIV diagnoses in the nation. Now, an estimated 16,000 Floridians have lost access to HIV and AIDS medications after an emergency rule from the Florida ...

The state invoked emergency rule-making power for what advocates say will be another emergency, when HIV-positive patients ...

More than 20 states are actively reducing or considering cutting back on their funding of programs helping people access HIV ...

Citing rising costs and shortfalls in federal support, about 20 states are toughening eligibility requirements for patients in drug assistance programs.

The emergence of Lilly’s bundling strategy for Zepbound and Taltz reflects the unregulated state of patient assistance programs in the commercial market and the need for Congressional intervention.

When Jayant Mishra was diagnosed with psoriatic arthritis last year, the California resident understood he’d likely need lifelong treatment to manage the autoimmune disease. After he was prescribed ...

Florida has issued cuts to the Aids Drug Assistance Program (ADAP), a federal-state partnership that provides free ...

As health insurance companies push back against co-pay assistance programs, patients are left to navigate the complex world of prescription medication costs.